| Primary |
| Product Used For Unknown Indication |
33.8% |
| Gout |
20.2% |
| Hyperuricaemia |
12.7% |
| Hypertension |
7.1% |
| Drug Use For Unknown Indication |
5.6% |
| Cardiac Failure |
3.7% |
| Colitis Ulcerative |
2.9% |
| Accidental Exposure |
2.1% |
| Pulmonary Tuberculosis |
1.9% |
| Prophylaxis |
1.4% |
| Blood Uric Acid Increased |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
| Chronic Lymphocytic Leukaemia |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Nephrolithiasis |
0.9% |
| Arrhythmia |
0.7% |
| Hyperlipidaemia |
0.7% |
| Inflammatory Bowel Disease |
0.7% |
| Cardiac Failure Chronic |
0.7% |
| Crohn's Disease |
0.7% |
|
| Drug Reaction With Eosinophilia And Systemic Symptoms |
14.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
12.8% |
| Stevens-johnson Syndrome |
11.7% |
| Toxic Epidermal Necrolysis |
11.1% |
| Rash |
6.9% |
| Renal Failure Acute |
5.6% |
| Human Herpesvirus 6 Infection |
5.0% |
| Vomiting |
4.1% |
| Renal Failure |
3.7% |
| Urticaria |
2.8% |
| White Blood Cell Count Decreased |
2.6% |
| Drug Ineffective |
2.4% |
| Rash Generalised |
2.4% |
| Transaminases Increased |
2.4% |
| Multi-organ Failure |
2.2% |
| Hepatitis |
2.0% |
| Leukopenia |
2.0% |
| Skin Exfoliation |
2.0% |
| Thrombocytopenia |
2.0% |
| Toxic Skin Eruption |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
26.5% |
| Drug Use For Unknown Indication |
18.8% |
| Hypertension |
12.7% |
| Hyperuricaemia |
7.0% |
| Gout |
5.5% |
| Prophylaxis |
4.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Diabetes Mellitus |
2.6% |
| Drug Abuse |
2.4% |
| Pain |
2.3% |
| Cardiac Failure |
2.2% |
| Chronic Lymphocytic Leukaemia |
2.1% |
| Adult T-cell Lymphoma/leukaemia |
2.0% |
| Hyperlipidaemia |
1.7% |
| Rheumatoid Arthritis |
1.5% |
| Hypercholesterolaemia |
1.4% |
| Thrombosis Prophylaxis |
1.2% |
| Atrial Fibrillation |
1.1% |
| Cardiac Failure Chronic |
1.1% |
| Depression |
1.0% |
|
| Stevens-johnson Syndrome |
11.4% |
| Renal Failure Acute |
9.6% |
| Toxic Epidermal Necrolysis |
9.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.8% |
| Thrombocytopenia |
6.8% |
| Rash |
6.7% |
| Renal Failure |
4.8% |
| Toxic Skin Eruption |
4.6% |
| Interstitial Lung Disease |
4.5% |
| Vomiting |
4.1% |
| Renal Impairment |
4.0% |
| Rhabdomyolysis |
4.0% |
| Venoocclusive Liver Disease |
4.0% |
| Pancreatitis Acute |
3.5% |
| Weight Decreased |
3.4% |
| White Blood Cell Count Increased |
3.3% |
| Pyrexia |
2.6% |
| Pancytopenia |
2.5% |
| Renal Failure Chronic |
2.2% |
| Completed Suicide |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.7% |
| Drug Use For Unknown Indication |
19.3% |
| Hypertension |
10.8% |
| Prophylaxis |
6.1% |
| Gout |
4.1% |
| Multiple Myeloma |
3.6% |
| Diffuse Large B-cell Lymphoma |
3.1% |
| Diabetes Mellitus |
3.0% |
| Pain |
3.0% |
| Hyperuricaemia |
2.4% |
| Atrial Fibrillation |
2.3% |
| Rheumatoid Arthritis |
1.9% |
| Chronic Lymphocytic Leukaemia |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Hepatitis C |
1.7% |
| Acute Myeloid Leukaemia |
1.6% |
| Blood Cholesterol Increased |
1.3% |
| Depression |
1.3% |
| Constipation |
1.2% |
| Nausea |
1.1% |
|
| Vomiting |
10.8% |
| Renal Failure Acute |
8.2% |
| Weight Decreased |
8.1% |
| Renal Failure |
6.6% |
| White Blood Cell Count Decreased |
6.4% |
| Thrombocytopenia |
6.2% |
| Death |
5.6% |
| Pneumonia |
4.9% |
| Pyrexia |
4.6% |
| Weight Increased |
4.4% |
| Sepsis |
4.3% |
| Rash |
4.2% |
| Renal Impairment |
4.0% |
| Rhabdomyolysis |
3.8% |
| Syncope |
3.6% |
| Myocardial Infarction |
3.0% |
| Nausea |
3.0% |
| Urinary Tract Infection |
2.9% |
| Flushing |
2.9% |
| Drug Ineffective |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
18.2% |
| Hypertension |
16.5% |
| Drug Use For Unknown Indication |
12.1% |
| Atrial Fibrillation |
9.5% |
| Gout |
9.0% |
| Hyperuricaemia |
9.0% |
| Hepatosplenic Candidiasis |
3.2% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Type 2 Diabetes Mellitus |
2.2% |
| Pneumonia |
1.9% |
| Routine Health Maintenance |
1.9% |
| Acute Promyelocytic Leukaemia |
1.7% |
| Cardiac Failure |
1.7% |
| Diabetes Mellitus |
1.7% |
| Nasopharyngitis |
1.7% |
| Anticoagulant Therapy |
1.5% |
| Arthritis |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Dental Care |
1.5% |
| Dry Mouth |
1.5% |
|
| Drug Interaction |
29.9% |
| Renal Failure Acute |
9.2% |
| Tremor |
8.0% |
| Rhabdomyolysis |
5.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.6% |
| Hyperkalaemia |
4.6% |
| Blood Creatinine Increased |
3.4% |
| Haemorrhage |
3.4% |
| Prothrombin Time Prolonged |
3.4% |
| Sinoatrial Block |
3.4% |
| Vomiting |
3.4% |
| Arrhythmia |
2.3% |
| Bone Marrow Failure |
2.3% |
| Gout |
2.3% |
| Melaena |
2.3% |
| Myositis |
2.3% |
| Oliguria |
2.3% |
| Pancytopenia |
2.3% |
| Periorbital Oedema |
2.3% |
| Rash |
2.3% |
|
